Business
Omeros Announces New Date for YARTEMLEA® Approval Conference Call
SEATTLE, December 26, 2025--Omeros Corporation (NASDAQ: OMER) today announced a revised date for its conference call to discuss the recent FDA approval of YARTEMLEA® (narsoplimab-wuug), the first and only therapy indicated for hematopoietic stem cell transplant-associated thrombotic microangiopathy (TA-TMA).
About this update from Omeros Corporation
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":342,"url":"https://media.zenfs.com/en/business-wire.com/18492f13588598035e37658aeae5992d"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/e4wEipDYvi7hOLOqggki6A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTY4NDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/18492f13588598035e37658aeae5992d","width":480,"height":342}},"lazy":false},{"type":"text","content":"— Omeros to Host Conference Call Wednesday, January 7, 2026 at 4:30 p.m. ET —","length":77,"tagName":"p","attribs":{}},{"type":"text","content":"SEATTLE, December 26, 2025--(BUSINESS WIRE)--Omeros Corporation (NASDAQ: OMER) today announced a revised date for its conference call to discuss the recent FDA approval of YARTEMLEA® (narsoplimab-wuug), the first and only therapy indicated for hematopoietic stem cell transplant-associated thrombotic microangiopathy (TA-TMA).","length":326,"tagName":"p"},{"type":"text","content":"To ensure broad participation following this significant milestone — and to accommodate shareholders’ and investors’ holiday schedules — the call will now take place on Wednesday, January 7, 2026 at 4:30 p.m. Eastern Time. Details for the webcast and registration remain unchanged and are provided below.","length":304,"tagName":"p"},{"type":"text","content":"We are excited to kick off the new year by sharing more about this landmark approval and our January 2, 2026 U.S. market launch of YARTEMLEA.","length":141,"tagName":"p"},{"type":"text","content":"Conference Call and WebcastWednesday, January 7, 2026 at 4:30 p.m. Eastern Time","length":80,"tagName":"p"},{"type":"text","content":"Live webcast: Access the live webcast at https://investor.omeros.com/upcoming-events.","length":85,"tagName":"p"},{"type":"text","content":"Conference call (phone): To join by phone, participants must register at https://register-conf.media-server.com/register/BI860d4c7c1e5d4bb1a77988a530e78171 to receive a unique PIN. After registering, you may either:","length":215,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"dial in using the conference line and PIN provided at the registration site; or","length":79,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"select the "Call Me" option to recei...